Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Korro Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$2.90 | -$2.34 | -$2.61 |
| Q2 2025 | 2 | -$2.67 | -$2.67 | -$2.67 |
| Q3 2025 | 2 | -$2.68 | -$2.68 | -$2.68 |
| Q4 2025 | 2 | -$2.76 | -$2.76 | -$2.76 |
| Q1 2026 | 1 | -$2.97 | -$2.97 | -$2.97 |
| Q2 2026 | 1 | -$2.95 | -$2.95 | -$2.95 |
| Q3 2026 | 1 | -$3.11 | -$3.11 | -$3.11 |
| Q4 2026 | 1 | -$3.25 | -$3.25 | -$3.25 |
Korro Bio, Inc. Earnings Date And Information
Korro Bio, Inc. last posted its earnings results on Tuesday, March 18th, 2025. The company reported $-2.26 earnings per share for the quarter, topping analysts' consensus estimates of $-2.33 by $0.07. The company had revenue of 2.27 M for the quarter and had revenue of 2.27 M for the year. Korro Bio, Inc. has generated $-9 earnings per share over the last year ($-9.37 diluted earnings per share) and currently has a price-to-earnings ratio of -1.27. Korro Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based on prior year's report dates.
Korro Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/18/2025 | Q4 2024 | -$2.33 | -$2.24 | 0.09 | $2.27 M | $2.27 M |
| 11/12/2024 | Q3 2024 | -$2.55 | -$2.26 | 0.29 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$2.40 | -$2.43 | -0.03 | $0 | $0 |
| 03/29/2024 | Q1 2024 | N/A | -$2.44 | N/A | N/A | $0 |
| 12/29/2023 | Q4 2023 | N/A | -$4.89 | N/A | N/A | $0 |
| 09/28/2023 | Q3 2023 | N/A | -$2.03 | N/A | N/A | $0 |
| 06/28/2023 | Q2 2023 | N/A | -$1.94 | N/A | N/A | $0 |
| 03/29/2023 | Q1 2023 | N/A | -$3.58 | N/A | N/A | $0 |
| 12/29/2022 | Q4 2022 | N/A | -$3.21 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | -$3.74 | N/A | $3.25 M | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$30.43 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$33.59 | N/A | $833,333 | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$31.07 | N/A | $31.00 M | $0 |
| 09/28/2021 | Q3 2021 | N/A | -$36.51 | N/A | $2.38 M | $0 |
| 06/28/2021 | Q2 2021 | N/A | -$25.78 | N/A | $6.71 M | $9.42 M |
| 03/30/2021 | Q1 2021 | N/A | -$29.86 | N/A | $8.13 M | $4.65 M |
| 12/30/2020 | Q4 2020 | N/A | -$15.13 | N/A | $8.35 M | $9.95 M |
| 09/29/2020 | Q3 2020 | N/A | -$8.07 | N/A | $5.88 M | $11.25 M |
| 06/29/2020 | Q2 2020 | N/A | -$9.70 | N/A | $6.15 M | $8.52 M |
| 03/30/2020 | Q1 2020 | N/A | -$7.96 | N/A | $5.86 M | $7.26 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Korro Bio, Inc. Earnings: FAQ's
Korro Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based offlast year's report dates.
In the previous quarter, Korro Bio, Inc. (:KRRO) reported $-2.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.33 by $0.07.
The conference call for Korro Bio, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Korro Bio, Inc.'s latest earnings report can be read online.
Korro Bio, Inc. (:KRRO) has a recorded annual revenue of $2.27 M.
Korro Bio, Inc. (:KRRO) has a recorded net income of $-83,581,000.Korro Bio, Inc. has generated $-9.37 earnings per share over the last four quarters.
Korro Bio, Inc. (:KRRO) has a price-to-earnings ratio of -1.27 and price/earnings-to-growth ratio is -0.06.